Skip to content

Clinical trials

Lung Diseases trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Austria Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20092
20102
20112
20141
20171
20182
20195
20212
20221
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting4
Unknown status4
Active, not recruiting2
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Vienna4
AstraZeneca3
Aeris Therapeutics2
Eli Lilly and Company2
United Therapeutics2
Bayer1
Integra LifeSciences Corporation1
Landeskrankenanstalten-Betriebsgesellschaft1
LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology1
Ludwig Boltzmann Institute for Lung Vascular Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases26
Respiratory Tract Diseases13
Pulmonary Disease, Chronic Obstructive9
Emphysema4
Lung Diseases, Obstructive4
Pathologic Processes4
Respiratory Aspiration4
Vascular Diseases4
Carcinoma, Non-Small-Cell Lung3
Cardiovascular Diseases3

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.